HoldsUp

Ben Bikman

Dr. Ben Bikman is a metabolic health specialist who focuses on metabolic dysfunction and insulin resistance. His work examines how lifestyle factors such as diet, exercise, and sleep influence metabolic health and can help reverse insulin resistance. He also evaluates the use and impact of weight loss medications, including Ozempic and other GLP-1 agonists.

96 claims checked on air: 17 context 13 contradicted 9 overstated 48 supported 9 unverified

What they said on air

0:02:01contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Administering exogenous insulin therapy to type 2 diabetics pushes insulin to supraphysiological levels and increases mortality risk.

"giving, say, a type 2 diabetic an insulin therapy. Now they're pushing the insulin from high to supraphysiological, all in an effort to control the glucose, little realizing that in the process you're actually killing them faster because so much of what kills the type 2 diabetic is not the hyperglycemia; it's the hyperinsulinemia and the insulin resistance." (said at 0:02:01)

The claim that administering exogenous insulin therapy to type 2 diabetics increases mortality risk ("killing them faster") due to hyperinsulinemia and insulin resistance is contradicted by high-certainty randomized controlled trial evidence. In the landmark ORIGIN trial (12,537 participants followed for a median of 6.2 years), basal insulin glargine targeted to normalize fasting glucose had a neutral effect on all-cause mortality and cardiovascular outcomes compared to standard care, without increasing mortality risk despite modest weight gain and increased hypoglycemic events.

0:07:07supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Acanthosis nigricans and skin tags are strong clinical physical indicators of insulin resistance.

"One of them is a condition called acanthosis nigricans... And then the other one people know is called skin tags... Both of those are very, very strong evidence of insulin resistance." (said at 0:07:07)

Extensive clinical and observational literature supports that both acanthosis nigricans and multiple skin tags (acrochordons) are well-recognized physical cutaneous indicators of hyperinsulinemia and insulin resistance. Mechanistically, elevated circulating insulin levels stimulate keratinocyte and fibroblast proliferation directly and via insulin-like growth factor-1 (IGF-1) receptors, leading to these epidermal changes. Acanthosis nigricans exhibits high specificity for insulin resistance, while multiple skin tags frequently serve as an early, sensitive physical marker prompting metabolic evaluation.

0:09:09needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Polycystic ovary syndrome (PCOS) is the most common cause of female infertility.

"polycystic ovary syndrome, the most common infertility in women" (said at 0:09:09)

The claim is broadly accurate but requires specific qualification. Polycystic ovary syndrome (PCOS) is established in clinical literature as the most common cause of anovulatory (ovulatory dysfunction) infertility in women, rather than the leading cause of all female infertility across all etiologies (which also include tubal disease, endometriosis, and diminished ovarian reserve).

0:09:09needs contexthighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Breast cancer is the most common cancer in women, and prostate cancer is the most common cancer in men.

"breast and prostate cancers, the two most common cancers in women and men respectively." (said at 0:09:09)

Breast cancer is indeed the most commonly diagnosed cancer among women both globally and regionally. However, whether prostate cancer is the most common cancer in men depends on the geographic population: globally, lung cancer is the most frequently diagnosed cancer in men (followed by prostate cancer), whereas in the United States and many high-income countries, prostate cancer is the most frequently diagnosed non-cutaneous cancer among men.

0:11:26supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Insulin directly affects every single cell in the human body.

"Insulin is one of the few peptide hormones that will literally affect every single cell of the body from brain cells to bone cells, lung cells to liver cells, and every cell in between. There's no exception. Insulin will have an effect at every cell of the body." (said at 0:11:26)

Published endocrinological literature confirms that insulin receptors are ubiquitously expressed across virtually all cell types in the human body—spanning classic metabolic target tissues (liver, skeletal muscle, adipose tissue) as well as non-classical targets including neurons, osteocytes, pulmonary cells, and immune cells. In addition to regulating cellular metabolism and glucose handling, insulin functions broadly as a growth and survival factor with mitogenic and signaling effects across cell types throughout the body.

0:11:47supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In erectile dysfunction associated with insulin resistance, insulin's ability to produce nitric oxide in endothelial vessels is impaired, causing reduced vasodilation.

"Like in the case of erectile dysfunction, insulin is less capable at producing nitric oxide in the endothelium of the blood vessels. So there's less vasodilation. Less vasodilation means compromised erectile function." (said at 0:11:47)

Under normal physiological conditions, insulin stimulates endothelial nitric oxide synthase (eNOS) activation primarily via the PI3K/Akt signaling pathway, producing nitric oxide (NO) and promoting vascular relaxation. In states of insulin resistance, this pathway is selectively impaired, blunting insulin-stimulated NO production and endothelium-dependent vasodilation. In the penile vasculature, this endothelial dysfunction reduces the vasodilatory capacity essential for penile erection, directly contributing to erectile dysfunction.

0:13:31supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Elevated stress hormones such as cortisol and epinephrine cause acute insulin resistance in humans within hours.

"And that is stress. So elevated stress hormones, whether it's cortisol or epinephrine/adrenaline, will cause acute insulin resistance in humans. As that stimulus goes away, the problem resolves." (said at 0:13:31)

Human experimental studies using hyperinsulinemic-euglycemic clamps demonstrate that acute elevations of stress hormones, such as epinephrine (adrenaline) and glucocorticoids, cause rapid insulin resistance within hours. Regional intra-arterial perfusion of adrenaline directly inhibits insulin-stimulated glucose uptake in human skeletal muscle within three hours. Furthermore, acute infusion of counter-regulatory stress hormones (epinephrine, hydrocortisone, glucagon, and growth hormone) simulating acute stress produces an 88% reduction in the insulin sensitivity index.

0:13:41supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Elevated inflammatory cytokines cause rapid insulin resistance in humans, rodents, and cell cultures.

"Next is inflammation. If you increase the levels of inflammatory cytokines in cells or rodents or humans, they will be insulin resistant very quickly." (said at 0:13:41)

Experimental studies in humans, rodents, and cell cultures demonstrate that acute administration of proinflammatory cytokines (such as TNF-alpha) rapidly induces insulin resistance. In healthy human volunteers, short-term infusion of TNF-alpha significantly increases homeostasis model assessment of insulin resistance (HOMA-IR) and impairs peripheral insulin sensitivity. In rodent models, acute 3-hour TNF-alpha infusions impair insulin-mediated muscle glucose uptake by over 50%. In cultured muscle cells, TNF-alpha exposure impairs insulin receptor substrate signaling and inhibits glucose uptake.

0:14:04supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

High levels of insulin itself directly cause insulin resistance in humans, rodents, and cell cultures.

"And then lastly of the primary fast causes of insulin resistance is too much insulin itself. So we know in humans, rodents, and cells—I've published my own work on this topic—that too much insulin will result in a resistance to the stimulus. So too much insulin can cause insulin resistance." (said at 0:14:04)

Experimental evidence in humans, animal models, and in vitro cell cultures demonstrates that sustained hyperinsulinemia directly induces insulin resistance. In controlled human metabolic studies, continuous hyperinsulinemic infusions over extended periods (e.g., 40 hours) significantly reduce subsequent insulin-stimulated glucose utilization and whole-body glucose disposal compared to controls, demonstrating that elevated insulin levels themselves directly induce peripheral insulin resistance via post-receptor desensitization and signaling downregulation.

0:14:40supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Bret Goodpaster and David Kelley demonstrated that lean, highly insulin-sensitive endurance athletes have intramuscular triglyceride levels as high as obese individuals with type 2 diabetes.

"Bret Goodpaster and David Kelley 30 years ago described this phenomenon of the athletes paradox, where they noted that in obesity with type 2 diabetes and insulin resistance, if you pull a muscle biopsy, there's really high levels of fat in the muscle of triglycerides, and they're very insulin resistant... And yet when they did muscle biopsies from very lean, exceptionally insulin-sensitive marathon runners, they had just as much fat in their muscle in the form of triglycerides as the obese type 2 diabetics did." (said at 0:14:40)

Bret Goodpaster, David Kelley, and colleagues formally described the 'athlete's paradox' in a 2001 physiological study comparing lean trained endurance athletes, sedentary lean individuals, obese individuals, and obese patients with type 2 diabetes. Using percutaneous vastus lateralis muscle biopsies and hyperinsulinemic-euglycemic clamps, they demonstrated that endurance-trained athletes had high insulin sensitivity alongside elevated intramyocellular lipid levels (2.36 ± 0.37% lipid area) comparable to those observed in insulin-resistant obese individuals and patients with type 2 diabetes (3.04 ± 0.39% lipid area).

0:15:47supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Ceramides directly block insulin signaling by inhibiting Akt phosphorylation.

"When insulin binds to its receptor, then you have a series of phosphorylation events. Ceramides block that very well. It's a very well-defined pathway. And if you can just do one thing and just resolve the ceramides, you correct the insulin signaling." (said at 0:15:47)

Extensive mechanistic research in cell culture and animal models confirms that ceramide accumulation impairs insulin signaling by inhibiting Akt/PKB activation and phosphorylation. Ceramides inhibit Akt through two main established pathways: activating atypical protein kinase C (PKC-zeta), which phosphorylates the Akt pleckstrin homology domain and prevents its translocation to the plasma membrane, and activating protein phosphatase 2A (PP2A), which directly dephosphorylates Akt. While other lipid intermediates (such as diacylglycerols) also contribute to overall insulin resistance, the specific pathway by which ceramides block insulin-stimulated Akt activation is well defined.

0:20:05contradictedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Elevated insulin directly inhibits the aromatase enzyme, impairing the conversion of testosterone into estrogens in the ovary.

"Insulin has a direct inhibitory role on aromatase, that enzyme that mediates the conversion and the synthesis of estrogens in men and women." (said at 0:20:05)

The claim that insulin has a direct inhibitory effect on aromatase contradicts established endocrinological literature. Rather than inhibiting aromatase (the enzyme that converts androgens to estrogens), insulin enhances or induces aromatase expression and activity in peripheral tissues such as adipose tissue and bone. In men and postmenopausal women with hyperinsulinemia and obesity, elevated insulin promotes adipose aromatase activity, driving increased conversion of testosterone into estrogens rather than impairing it.

0:20:51contradictedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Cultured fat cells will not expand or accumulate lipid droplets from surrounding calories in vitro until insulin is introduced.

"Everything the fat cell needs—all the calories that fat cell could ever want are around it right now. And yet they're teeny little cells. They're not getting big at all until we add one thing. And the moment we add insulin into that culture, now the fat cells start to get big. If we check them 6 hours later, there's a big lipid droplet." (said at 0:20:51)

The claim asserts that cultured fat cells cannot expand or accumulate lipid droplets in vitro from available nutrients until insulin is added. However, in vitro research on adipocyte biology demonstrates that fat cells can take up exogenous free fatty acids and accumulate lipid droplets independently of insulin. In fact, experimental studies investigating lipid droplet enlargement from fatty acids (such as oleic acid) show that lipid accumulation occurs in culture and that insulin is not an absolute requirement for droplet formation; in some direct culture models, adding insulin actually attenuated fatty acid-induced lipid droplet enlargement.

0:23:39supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

George Cahill fasted human subjects for multiple days and administered insulin to drop blood glucose to approximately 20 mg/dL while they remained conscious.

"In fact, Dr. George Cahill did these studies about 40 years ago; you could never get IRB approval to do it now—he would fast men for days and then give them an insulin dose and drive their glucose levels down to about 20 milligrams per deciliter, just to see how low could the glucose get and the person maintains consciousness. And they did." (said at 0:23:39)

The speaker accurately describes classic metabolic research demonstrating that after prolonged fasting, human subjects given insulin challenges remain conscious and asymptomatic despite severe hypoglycemia. Landmark work by George Cahill's group established that ketones replace glucose as the primary fuel for the brain during starvation (Owen et al., 1967), and Drenick et al. (1972) specifically administered insulin to men fasted for two months, driving blood glucose down to levels as low as 0.5 mmol/L (9 mg/dL)—well below 20 mg/dL—without precipitating hypoglycemic reactions or loss of consciousness.

0:26:38needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Lowering insulin increases daily resting energy expenditure by 200 to 500 calories.

"a higher metabolic rate by several hundred calories a day when insulin goes down. So the body's just burning a little hotter. The engine is revving higher. So the overall energy expenditure is up, again, by 200 to 500 calories a day." (said at 0:26:38)

The speaker's figures of 200 to ~500 calories per day come from controlled feeding trials evaluating the carbohydrate-insulin model of obesity during weight-loss maintenance. In a randomized trial of 164 adults (Ebbeling et al., 2018), lowering dietary carbohydrate increased total energy expenditure (TEE) by 209 kcal/day in intention-to-treat analysis (278 kcal/day per protocol), and by 308 to 478 kcal/day among participants in the highest tertile of baseline insulin secretion. A subsequent meta-analysis of 29 controlled-feeding studies found that trials lasting longer than 2.5 weeks showed a mean increase of 135 kcal/day on lower-carbohydrate diets. However, this effect applies to total daily energy expenditure (TEE) during weight-loss maintenance rather than resting energy expenditure (REE) alone (which shows smaller changes), and the magnitude and universality of this metabolic advantage remain an area of ongoing debate.

0:26:59contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Excreting ketones in breath and urine during ketosis causes the body to lose up to several hundred calories per day, contributing to a net waste of up to 800 calories per day.

"And when you're in ketosis, you're eliminating ketones through the breath and the urine. And every ketone that a person's breathing out or urinating out has a caloric value roughly similar to glucose. So you're just excreting calories from the body. So the net effect of all of that can be up to 800 or so calories a day that the person's just wasting." (said at 0:26:59)

The claim that ketone excretion in urine and breath during ketosis causes an energy waste of up to several hundred or 800 calories per day is contradicted by metabolic ward studies and reviews of dietary thermodynamics. Rigorous clinical trials measuring 24-hour energy expenditure in metabolic chambers show that switching to an isocaloric ketogenic diet produces only minor shifts in energy expenditure (around 57 to 150 kcal/day), with ketone excretion contributing negligible caloric loss, far below the asserted 800 calories per day.

0:29:16supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In cell culture models, treating cells with the saturated fat palmitate causes insulin resistance via conversion into ceramides, whereas treatment with monounsaturated or polyunsaturated fatty acids does not.

"in cell cultures, if you treat cells with saturated fat, palmitate, which is the main saturated fat in the body, you get insulin resistance very quickly. Now, if you block ceramides, you resolve that insulin resistance. If you treat those cells with monounsaturated fatty acid, no insulin resistance. If you treat those cells with polyunsaturated fatty acid, no insulin resistance." (said at 0:29:16)

In vitro cell culture studies in skeletal muscle cells (such as C2C12 myotubes and human myotubes) demonstrate that exposure to the saturated fatty acid palmitate causes insulin resistance by promoting de novo synthesis of ceramides, which impairs Akt/PKB activation and insulin-stimulated glucose metabolism. Inhibiting ceramide synthesis prevents or restores insulin signaling following palmitate treatment. In contrast, monounsaturated fatty acids such as oleate do not induce ceramide accumulation or impair Akt activation. Because the claim specifies effects in cell culture models, it is supported by in vitro literature, though certainty is rated very low due to the purely cell-culture nature of the evidence.

0:30:27supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Co-incubating cells with oleic acid or linoleic acid reverses palmitate-induced insulin resistance.

"we would treat cells with palmitate, cause insulin resistance, co-treat them, co-incubate the cells with either oleic acid or linoleic acid, and we would reverse the insulin resistance." (said at 0:30:27)

The claim accurately describes in vitro cell culture findings. In skeletal muscle cells (such as cultured rat and human myotubes) and other cell models, palmitate (a saturated fatty acid) induces insulin resistance, whereas co-treatment or pre-incubation with unsaturated fatty acids—specifically monounsaturated fatty acids like oleic acid or polyunsaturated fatty acids like linoleic acid—blocks or reverses palmitate-induced impairments in insulin signaling (e.g., Akt phosphorylation). Because this is based strictly on in vitro cell culture models, the GRADE certainty is very low.

0:30:53supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

All dietary animal sources of fat contain some amount of linoleic acid.

"literally any animal source of fat, any animal food has some linoleic acid in it. It's ubiquitous." (said at 0:30:53)

Linoleic acid (an essential 18-carbon omega-6 polyunsaturated fatty acid) is ubiquitous across dietary animal fats, including beef tallow, lard, poultry fat, dairy fat, eggs, and seafood. Because animals obtain linoleic acid through their diets (from plants, grains, or forage) and incorporate it into cellular membranes and adipose triglycerides, all animal lipid sources naturally contain varying proportions of linoleic acid.

0:31:40supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

When carbohydrate intake is reduced, humans can consume two to four times more saturated fat while maintaining significantly lower circulating plasma saturated fat levels.

"you can have humans that if the carbohydrate levels are going down, they can eat two or three or four times more saturated fat than a high-carb group. And then their circulating levels of saturated fat, so the saturated fat in the plasma, is significantly lower." (said at 0:31:40)

Randomized controlled feeding trials demonstrate that when dietary carbohydrate intake is restricted, individuals consuming substantially higher levels of saturated fatty acids (e.g., doubling or tripling intake) exhibit stable or reduced levels of circulating saturated fatty acids and palmitoleic acid (a marker of de novo lipogenesis) compared to baseline or low-fat, high-carbohydrate diets.

0:32:22contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Palmitate is the primary saturated fatty acid produced by the liver via de novo lipogenesis.

"When the liver is told to make fat through de novo lipogenesis, the fat that it makes is palmitate. So most of the fat, most of the saturated fat we have flowing through our blood that's going to get to a cell is going to be coming from what the liver is making, not from what we're eating." (said at 0:32:22)

The speaker's statement combines two distinct claims: (1) that palmitate is the primary fat synthesized by hepatic de novo lipogenesis (DNL), and (2) that most circulating (saturated) fat originates from hepatic DNL rather than dietary intake or adipose stores. While the first claim is biochemically accurate—palmitate (palmitic acid) is the primary product synthesized via fatty acid synthase during DNL—the second claim is contradicted by human metabolic tracer studies. Stable isotope kinetic studies consistently demonstrate that hepatic DNL accounts for only a minor fraction (typically ~3% to 5% in lean, healthy individuals, and ~10% to 25% in individuals with obesity, insulin resistance, or steatohepatitis) of circulating fatty acids and VLDL triglycerides. The vast majority of circulating saturated and non-esterified fatty acids originate from adipose tissue lipolysis (systemic NEFA) and dietary intake.

0:33:25needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Studies in the European Journal of Clinical Nutrition showed that a high-carbohydrate, high-saturated-fat diet produced the worst insulin resistance and insulin signaling outcomes.

"it was some groups in Europe in the European Journal of Clinical Nutrition where they had, in the context of a high-carb diet and then manipulating the saturation of fats, the high-carb and high-saturated fat was the worst for insulin resistance and insulin signaling." (said at 0:33:25)

The speaker accurately describes the findings of landmark European dietary intervention research, though the primary multicenter trial was published in Diabetologia (the KANWU study) rather than the European Journal of Clinical Nutrition. In the randomized controlled KANWU trial (n=162 healthy adults), replacing monounsaturated fatty acids with saturated fatty acids significantly impaired insulin sensitivity (-10%), with the impairment concentrated in individuals consuming a total fat intake below the median (<37% of total energy, corresponding to a higher background carbohydrate intake, where insulin sensitivity was 12.5% lower on the saturated fat diet and 8.8% higher on the monounsaturated diet).

0:36:00supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Medium-chain triglycerides (MCTs) do not serve as substrates for ceramide synthesis.

"which is not a substrate for ceramides. So, it doesn't quite fit." (said at 0:36:00)

The rate-limiting initial step of de novo sphingolipid and ceramide biosynthesis is catalyzed by serine palmitoyltransferase (SPT), which conjugates L-serine with long-chain fatty acyl-CoAs—predominantly palmitoyl-CoA (C16), and to a lesser extent other long-chain acyl-CoAs ranging from C14 to C18. Medium-chain fatty acids/triglycerides (MCTs, typically C6–C12) do not serve as substrates for SPT or the de novo ceramide synthesis pathway.

0:36:56contradictedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Fructose does not directly elicit an insulin response.

"No, fructose itself will not elicit an insulin response whatsoever." (said at 0:36:56)

While fructose does not directly stimulate pancreatic beta-cell insulin exocytosis through standard glucose-sensing pathways to the same extent as glucose, the claim that fructose does not elicit an insulin response 'whatsoever' is contradicted by in vivo findings. Ingestion of fructose acutely stimulates circulating insulin release in both humans and preclinical models. This physiological insulin response is primarily mediated through an indirect gut-pancreas axis, where intestinal fructose metabolism triggers the secretion of glucagon-like peptide-1 (GLP-1), which in turn stimulates pancreatic insulin secretion.

0:39:01supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In Kevin Hall's 2021 ad libitum feeding study, subjects on a plant-based high-carbohydrate diet spontaneously consumed approximately 700 fewer calories per day than those on a ketogenic diet.

"they found that the higher-carb group spontaneously ate about 700 calories a day less." (said at 0:39:01)

In a 2021 randomized crossover inpatient feeding trial led by Kevin D. Hall, 20 adults consumed either a plant-based, low-fat, high-carbohydrate diet (75.2% carbohydrate) or an animal-based, ketogenic, low-carbohydrate diet (10.0% carbohydrate) ad libitum for two weeks before switching to the alternate diet. Participants spontaneously consumed an average of 689 ± 73 kcal per day less on the high-carbohydrate, low-fat diet than on the ketogenic diet across the two-week period (and 544 ± 68 kcal/day less during the final week), matching the claim of approximately 700 calories per day less.

0:40:08overstatedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Carbohydrates account for roughly 70% of total calories consumed globally and about 60% in the United States.

"70% of all calories consumed globally, it's about 60% in the US, are carbohydrates." (said at 0:40:08)

Nationally representative dietary data demonstrate that the proportion of total calories derived from carbohydrates is substantially lower than stated, particularly for the United States. Analysis of National Health and Nutrition Examination Survey (NHANES) cycles from 1999 to 2016 found that carbohydrates accounted for 50.5% of total energy intake in US adults (down from 52.5% in 1999), not ~60%. Globally, carbohydrate intake varies widely by country and economic development—ranging from under 50% in parts of North America and Europe to over 65% in low-income regions—making a blanket global estimate of 70% an overstatement of the worldwide average.

0:42:22unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Francis Benedict and Elliott P. Joslin found that metabolic rate was approximately 20% elevated in severe type 1 diabetes.

"Francis Benedict, who you and I may recall wrote, created what's called the Benedict equation... he collaborated with Elliott P. Joslin... They found that their metabolic rate was about 20% too high." (said at 0:42:22)

No published record matching the specific historical data or collaborative publications of Francis G. Benedict and Elliott P. Joslin regarding metabolic rate elevations in severe diabetes was located; this does not prove the claim false.

0:43:02supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A study by Nair and colleagues demonstrated that insulin administration in type 1 diabetes begins to reduce the elevated metabolic rate within minutes.

"a group at Minnesota, the first author is Nair, N-A-I-R, they not only confirmed the findings from 60 or 70 years earlier that in type 1 diabetes the metabolic rate is too high, like something's broken, they're burning too hot, but when you gave them insulin, within minutes the metabolic rate began to slow down." (said at 0:43:02)

Research by K. Sreekumaran Nair and colleagues established that poorly controlled or insulin-deprived type 1 diabetes is characterized by an elevated basal/resting metabolic rate and increased catabolism, confirming early metabolic observations. Their interventional physiology studies demonstrated that acute intravenous insulin replacement rapidly suppresses protein breakdown and reduces elevated energy expenditure/resting metabolic rate back toward baseline levels.

0:43:15overstatedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Lowering insulin levels increases adipose tissue metabolic rate and mitochondrial uncoupling in humans.

"We found in human work that part of it is because the fat tissue starts having a much higher metabolic rate when insulin comes down. There's much more mitochondrial uncoupling." (said at 0:43:15)

The assertion overstates the findings of the human literature. While preclinical rodent experiments demonstrate that chronic hyperinsulinemia reduces mitochondrial uncoupling and respiration in adipose tissue, the human data from this research group evaluated the effects of ex vivo ketone (β-hydroxybutyrate) exposure on biopsied human subcutaneous adipose tissue, which increased mitochondrial respiration without increasing ATP production. Direct evidence establishing that lowering insulin in humans increases whole-tissue adipose metabolic rate via mitochondrial uncoupling in vivo is preliminary and primarily extrapolated from cell culture, rodent models, and ex vivo tissue assays.

0:44:50unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A published study in women found that adopting a low-carbohydrate diet resulted in greater metabolic improvements than participating in a structured, intense strength-training program.

"There was a paper published in women where they looked at a very structured and intense exercise program with—I think it was just low-carb diet, and the low-carb diet had better metabolic improvements than the strength training did." (said at 0:44:50)

No published record matching the claim that a study in women found a low-carbohydrate diet yielded greater metabolic improvements than a structured strength-training program was located; this does not prove the claim false. Existing randomized trials in women generally evaluate carbohydrate restriction combined with resistance training rather than directly comparing diet alone against strength training alone.

0:46:12needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Skeletal muscle accounts for roughly 80% of glucose uptake during glucose clearance.

"When if someone's wearing their CGM and they see the glucose come up and down, 80% of that coming down is what's going in to fuel the muscle." (said at 0:46:12)

Under conditions of high physiological hyperinsulinemia (such as during hyperinsulinemic-euglycemic clamp studies), skeletal muscle is well established as the primary site of peripheral insulin-mediated glucose disposal, accounting for approximately 70–80% of total body glucose uptake. However, applying this figure directly to ordinary postprandial glucose curves observed on a continuous glucose monitor (CGM) requires qualification. Following meal ingestion, postprandial glucose homeostasis involves multiple concurrent processes: suppression of endogenous hepatic glucose production, splanchnic (hepatic and gut) glucose uptake, and peripheral disposal across muscle and adipose tissue, meaning skeletal muscle accounts for a smaller proportion (typically 30–50%) of total postprandial glucose clearance than the 80% measured under clamp conditions.

0:49:29unverifiedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Minute-for-minute over short durations such as 30 minutes per day, strength training leads to greater improvements in insulin sensitivity than aerobic training.

"there are studies to show that minute-for-minute at that shorter end, if a person's spending I think it was like 30 minutes a day, the strength-training group had better improvements in insulin sensitivity than the aerobic training group." (said at 0:49:29)

No published record matching the specific claim that short-duration (e.g., 30 minutes per day) strength training yields greater minute-for-minute improvements in insulin sensitivity than aerobic training was located; this does not prove the claim false. Broad comparative exercise literature typically demonstrates that both aerobic and resistance training improve insulin sensitivity, with combined training or high-intensity aerobic exercise often showing comparable or superior improvements to strength training alone.

0:55:02unverifiedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Singapore has higher rates of diabetes than the United States.

"Why would the beautiful little island of Singapore care so much about diabetes when the average Singaporean is incredibly lean? Because their rates of diabetes are higher than ours by a lot. We're not even close to the most diabetic country." (said at 0:55:02)

No published record matching the claim that Singapore has higher rates of diabetes than the United States was located; this does not prove the claim false.

0:55:41supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Human studies on time-restricted eating comparing a breakfast-plus-lunch feeding window to a lunch-plus-supper window show superior metabolic outcomes when meals are eaten earlier in the day.

"studies that have looked at humans finding where they do the kind of intermittent fasting or time-restricted eating of you have one group eat breakfast and lunch, one group eat lunch and supper, the lunch and supper group has worse outcomes. Not that they're not better. I mean, any one of those is better than the standard, but when you compare the two, the outcomes are better for the meals being earlier in the day." (said at 0:55:41)

Randomized trials and systematic reviews/network meta-analyses directly comparing early time-restricted eating (eTRE, e.g., breakfast and lunch window ending late afternoon) to late time-restricted eating (lTRE, e.g., lunch and dinner window ending in the evening) show that both forms of TRE generally improve metabolic markers compared to unrestricted usual diets, but eTRE yields superior outcomes on key cardiometabolic indices, particularly glycemic control, fasting glucose, fasting insulin, and body fat reduction. A systematic review and network meta-analysis of randomized controlled trials (PMID: 41586347) directly comparing early TRE to late TRE found that eTRE significantly reduced body weight (mean difference -1.15 kg, 95% CI -1.86 to -0.45) and fasting insulin (-3.32 μIU/mL, 95% CI -5.36 to -1.28) compared to lTRE with high certainty of evidence, and consistently ranked highest across glycemic and anthropometric parameters. Individual 3-month randomized controlled trials (PMID: 40250088, PMID: 40731289) also found that eTRE combined with energy restriction led to greater reductions in body fat mass, fasting glucose, and leptin levels compared to lTRE combined with energy restriction.

0:57:30overstatedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Hyperglycemia activates the sympathetic nervous system and raises core body temperature.

"one of the most common causes of being too hot is hyperglycemia. Most people don't appreciate that. When your blood glucose levels spike, you you activate your sympathetic nervous system." (said at 0:57:30)

Acute increases in glucose levels do stimulate sympathetic nervous system activity and contribute to diet-induced thermogenesis (energy expenditure and heat production), mediated in part by central autonomic pathways. However, characterizing hyperglycemia or glucose spikes as 'one of the most common causes of being too hot' is overstated, as postprandial thermogenesis produces only modest changes in body heat compared to typical causes of feeling overheated (such as environmental heat, physical exertion, vasomotor symptoms, fever, or thyroid disorders).

1:01:04overstatedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In an isocaloric study where protein was clamped, subjects consuming a high-carbohydrate breakfast experienced a more rapid return of hunger and ate more calories at their subsequent meal compared to those consuming a low-carbohydrate breakfast.

"and they looked at breakfast and the name of the article was something like more rapid return of hunger. It was something like return to hunger was in the title. And if the breakfast, isocaloric breakfast, so same number of calories, protein was clamped, and it just differed in the ratio of fats to carbs, the high-carb group was hungrier much sooner and then ate more for their next meal than the low-carb group." (said at 1:01:04)

The speaker accurately identifies the specific study titled 'Return of hunger following a relatively high carbohydrate breakfast is associated with earlier recorded glucose peak and nadir' (Diaz et al., 2014). In this controlled trial of 64 overweight adults, subjects received isocaloric breakfasts with protein clamped at 18% of calories, differing only in carbohydrate and fat content (55% carb / 27% fat vs. 43% carb / 39% fat). As claimed, subjects consuming the higher-carbohydrate breakfast experienced an earlier glucose peak/nadir and an earlier return of hunger (higher appetite at 3 and 4 hours postprandial). However, the claim is overstated because the study only measured subjective appetite ratings and circulating metabolites over a 4-hour postprandial window; it did not provide a subsequent ad libitum meal or measure calorie intake at the next meal.

1:07:50supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A continuous intravenous infusion of adrenaline (epinephrine) in humans produces demonstrable insulin resistance within one to two hours.

"If you do a steady little drip in a human of adrenaline, they're going to be insulin resistant with demonstrably insulin resistant within just an hour or two." (said at 1:07:50)

Human experimental studies using hyperinsulinemic-euglycemic clamps and arterial/venous perfusion techniques demonstrate that continuous infusion of adrenaline (epinephrine) rapidly induces acute insulin resistance, markedly suppressing insulin-mediated peripheral glucose uptake and stimulating lipolysis within 1 to 3 hours.

1:08:09supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Caffeine increases epinephrine levels, which in turn causes acute insulin resistance.

"Well, more caffeine is going to increase epinephrine even more. Epinephrine causes insulin resistance." (said at 1:08:09)

Randomized controlled crossover trials in humans demonstrate that acute caffeine administration stimulates the release of catecholamines, resulting in marked increases in plasma epinephrine levels and an acute reduction in whole-body insulin sensitivity (acute insulin resistance). In hyperinsulinemic-euglycemic clamp studies, caffeine administration increased plasma epinephrine roughly fivefold and reduced insulin sensitivity by approximately 15%, an effect mediated in part by epinephrine-induced lipolysis and adrenergic inhibition of peripheral glucose uptake.

1:10:24supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Exposure to cigarette smoke particles promotes ceramide accrual, forced mitochondrial fission, and insulin resistance.

"and we published another report looking at cigarette smoke with the cigarette smoke particles. That was purely in the context of ceramides, forced mitochondrial fission, and insulin resistance, and the cigarette smoke did all of those things." (said at 1:10:24)

The speaker accurately summarizes findings from preclinical research published by their laboratory examining the metabolic consequences of cigarette smoke and sphingolipid metabolism. In mouse and cell culture models, exposure to cigarette smoke or smoke-exposed conditioned medium promoted ceramide biosynthesis and accumulation, impaired mitochondrial respiration, and induced insulin resistance, which was prevented by inhibiting ceramide synthesis (Thatcher et al., 2014). In related mechanistic work from the same group, ceramide accrual directly triggered dynamin-related protein 1 (Drp1)-mediated mitochondrial fission and suppressed insulin signaling, with Drp1 inhibition protecting against metabolic disruption (Smith et al., 2013). Because the evidence is derived exclusively from in vitro and animal models, the GRADE certainty is very low.

1:10:36supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In pair-fed animal studies, inhalation of PM2.5 diesel exhaust particles at physiological levels resulted in adipocyte hypertrophy and increased total body fat mass despite identical caloric intake.

"The newer paper that we published about a year or two ago was I think the first to find that if you just have increased diesel exhaust particles, even when we calorie-clamped these we pair-fed these animals, and the animals that were inhaling more of the diesel particles at physiological levels, like at a level that a human could be exposed to, they had much fatter fat cells. So they had much more adipocyte hypertrophy, um which accounted for a higher body fat mass even though they were eating the exact same amount of calories." (said at 1:10:36)

A 2024 study in mice evaluated exposure to diesel exhaust particles (DEPs) compared to room air, finding that DEP exposure resulted in a robust shift in adipocyte hypertrophy and changes in fat mass, accompanied by altered adipose mitochondrial bioenergetics and elevated inflammatory markers. Subsequent animal work similarly confirmed that diesel particulate matter exposure induces adipocyte hypertrophy across subcutaneous and visceral fat depots. Because the supporting evidence relies exclusively on rodent models, the grade of certainty for human health outcomes is very low.

1:11:12contradictedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Chemicals such as diethylstilbestrol and bisphenol A (BPA) have been shown to promote adipose tissue expansion independent of changes in caloric intake.

"We've not done work on microplastics or the plasticizers, those like diethylstilbestrol and and BPA, but those also have been shown to promote greater fat expansion in the absence of calorie changes." (said at 1:11:12)

The assertion that endocrine disruptors like bisphenol A (BPA) and diethylstilbestrol (DES) promote adipose tissue expansion independent of changes in caloric intake is contradicted by rodent evidence demonstrating that early-life exposure alters hypothalamic feeding circuits, leading to increased food intake (hyperphagia). In CD-1 mice exposed perinatally to BPA, adult female offspring developed increased adiposity and body weight specifically alongside increased food consumption ('ate more') when fed a high-fat diet, rather than expanding fat mass in the absence of calorie changes.

1:15:37needs contexthighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Cholesterol synthesis pathways produce an essential component of the mitochondrial electron transport system.

"cholesterol is a precursor to an essential component of the electron transport system. And so, it's no surprise that if people are waging war on cholesterol synthesis, the mitochondria may suffer." (said at 1:15:37)

The statement is biochemically accurate regarding the pathway and its physiological consequences, but contains a slight chemical misstatement: cholesterol itself is not the precursor to components of the electron transport chain. Rather, the mevalonate pathway—the biosynthetic pathway responsible for producing cholesterol—branches off upstream at intermediate isoprenoids (such as farnesyl pyrophosphate) to synthesize ubiquinone (coenzyme Q10), an essential electron carrier in the mitochondrial respiratory chain. Consequently, pharmacological inhibition of cholesterol synthesis using HMG-CoA reductase inhibitors (statins) decreases the production of mevalonate and downstream coenzyme Q10, which can contribute to mitochondrial dysfunction and statin-associated muscle symptoms.

1:16:08supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Middle-aged and older women initiating statin therapy have a 50% increased risk of developing type 2 diabetes.

"And in women, middle-aged and older women have a 50% greater risk of developing type 2 diabetes when they get on a statin." (said at 1:16:08)

In a prospective analysis of 153,840 postmenopausal women aged 50–79 years enrolled in the Women's Health Initiative (Culver et al., 2012), statin use was associated with an adjusted 48% increased hazard of incident diabetes (multivariate-adjusted HR 1.48, 95% CI 1.38–1.59), which directly aligns with the speaker's claim of a 50% increase. While broader meta-analyses across general populations typically report a smaller relative increase (~9–12%), observational cohort data specifically examining middle-aged and older postmenopausal women observed this ~50% increased relative risk.

1:16:18supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Prescribed corticosteroids promote rapid weight gain and insulin resistance by activating the glucocorticoid stress pathway.

"So if a person has an autoimmune disease or a chronic inflammatory condition and the clinician has prescribed a corticosteroid, they're going to gain weight very, very quickly because that starts to play on that stress pathway where the more cortisol is that pathway is being activated, which is what that's doing, the more you're going to make the body insulin resistant." (said at 1:16:18)

Prescription glucocorticoids (corticosteroids) bind to glucocorticoid receptors—the primary mediators of the physiological stress hormone cortisol—and promote insulin resistance, impaired glucose uptake, increased hepatic gluconeogenesis, and central weight gain (features of iatrogenic Cushing's syndrome). Comprehensive endocrinology reviews confirm that insulin resistance and weight gain are prominent adverse metabolic effects of systemic corticosteroid therapy in inflammatory and autoimmune diseases.

1:16:55needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Atypical antipsychotics with the suffix '-apine' promote weight gain, likely mediated by hypothalamic insulin resistance that reduces satiety signaling.

"And then just for the sake of time, perhaps I just mention the atypical antipsychotics. Any drug that ends with an -apine at the end of it, the suffix being -apine, is generally going to promote weight gain. That's probably through a central insulin resistance of the hypothalamus. When the hypothalamus becomes insulin resistant, you have a reduced satiety signal and the person's just going to start eating more." (said at 1:16:55)

Atypical antipsychotics ending in the suffix '-apine' (notably clozapine, olanzapine, and quetiapine) carry the highest risk of weight gain and metabolic disruption among psychiatric medications. These agents act centrally within the hypothalamus, disrupting satiety signaling, appetite neuropeptides, and central insulin/glucose pathways. However, framing hypothalamic insulin resistance as the primary driver of increased food intake oversimplifies the mechanism: the dominant, well-established pharmacological triggers of antipsychotic-induced hyperphagia are antagonism of hypothalamic histamine H1 and serotonin 5-HT2C receptors and subsequent hypothalamic AMPK activation, alongside central and peripheral metabolic disturbances.

1:18:08supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In a clinical study of 11 women with newly diagnosed type 2 diabetes (average baseline HbA1c of 8.9%), 90 days of dietary lifestyle intervention reduced average HbA1c to 5.6% without medication.

"We published a clinical report. So collaborating with a local clinic in Utah, we took 11 women with newly diagnosed type 2 diabetes and their A1C was 8.9%, so very much diabetic range... And in just 90 days, their A1C went down. The average A1C was 8.9 and it went to 5.6. So no sign of diabetes whatsoever after just 90 days without a pill popped or a needle injected." (said at 1:18:08)

The speaker accurately recounts a published clinical case series of 11 women with newly diagnosed type 2 diabetes who underwent a 90-day low-carbohydrate ketogenic dietary intervention (<30 g carbs/day). Baseline HbA1c averaged 8.9% and decreased to 5.6% at 90 days alongside reductions in body weight, blood pressure, and triglycerides. Because this was a very small (n=11), uncontrolled clinical case series without a comparison group or long-term follow-up, the certainty of evidence for general efficacy is very low.

1:20:25supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Human studies show that co-ingestion of fat with protein following exercise stimulates greater muscle protein synthesis than protein ingestion alone.

"There's studies in humans to show that people work out, give them protein, they'll have a certain degree of muscle protein synthesis. If you give them protein and fat, it's even higher than it was with just the protein alone." (said at 1:20:25)

Human randomized trial evidence supports this claim. In a randomized crossover study of 10 resistance-trained young men, post-exercise ingestion of whole eggs (18 g protein plus 17 g fat) stimulated myofibrillar protein synthesis to a significantly greater extent than an isonitrogenous amount of egg whites (18 g protein with 0 g fat), despite similar overall systemic leucine availability.

1:20:55supportedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Bile acids secreted from the gallbladder enhance the activity of intestinal proteolytic enzymes.

"And that's most people don't appreciate that bile, when the gallbladder from the liver releases the bile into the intestines, we always just think of that as being relevant to fat digestion, and it's critical for that, but it also enhances proteolytic enzymes. It makes the proteolytic enzymes more active, they work better." (said at 1:20:55)

Published biochemical and physiological literature supports the claim. Beyond their primary role in emulsifying dietary fats, bile salts and human bile enhance the activation of intestinal proteolytic zymogens, such as the autocatalytic conversion of trypsinogen to active trypsin (up to 55-fold in vitro), and facilitate enterokinase-mediated activation of proteases in the small intestine. Because the supporting evidence comes primarily from mechanistic in vitro assays and animal/ex vivo models, the GRADE certainty is graded as low.

1:22:50overstatedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Performing 10 to 15 minutes of physical activity immediately following a meal reduces the postprandial glucose excursion by 50% or more.

"where if you just do 10 to 15 minutes of physical activity after your biggest glucose-spiking meal, you will blunt that glucose excursion by half if not even better." (said at 1:22:50)

Engaging in 10 to 15 minutes of light-to-moderate physical activity (such as walking) after a meal significantly attenuates postprandial glucose excursions compared with remaining sedentary. However, the claim that a 10- to 15-minute bout will blunt the glucose excursion by "half if not even better" (50% or more) is overstated. Meta-analyses and randomized crossover trials evaluating 10- to 15-minute bouts of postprandial walking typically show a moderate reduction in glucose incremental area under the curve (iAUC) and peak concentrations, on the order of 12% to 22% (and standardized effect sizes around -0.72), rather than a 50% or greater decrease.

1:25:20supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Acetic acid reduces hepatic gluconeogenesis and stimulates GLUT4 translocation in muscle cells via AMPK activation.

"where the acetic acid will reduce hepatic gluconeogenesis to help control glucose, which is very relevant in a person with diabetes, especially type 2... Apple cider vinegar will inhibit that, and so it helps the blood glucose by just having the liver dump less glucose into the blood. But it also stimulates—and you'd mentioned GLUT4 at the muscle... AMPK gets turned on through a series of events that moves GLUT4. Well, apple cider vinegar will do the same thing in the absence of exercise, albeit to a more modest degree." (said at 1:25:20)

Preclinical in vitro and animal studies support the claim that acetic acid activates AMP-activated protein kinase (AMPK) in both liver and skeletal muscle, resulting in increased GLUT4 expression/translocation in muscle cells and suppression of hepatic lipid/glucose metabolic pathways. Specifically, studies in L6 skeletal myotubes and diabetic rat models show that acetic acid directly induces AMPK phosphorylation, stimulates GLUT4 expression and muscle glucose uptake, and decreases hepatic lipogenic and gluconeogenic gene expression. Because the specific cellular pathway is verified in cell cultures and animal models rather than in human tissue biopsy trials, the GRADE certainty is very low.

1:28:16supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Beta-hydroxybutyrate acts as a signaling molecule through cell-surface G-protein coupled receptors to produce anti-inflammatory and antioxidant effects.

"the ketone is unique because on one hand it's a nutrient, it's a calorie to be burned, but on the other hand it's a signaling molecule, and it is known to elicit some of its signaling like anti-inflammatory effects and antioxidant effects. Part of it is through changes elicited because of a G-protein coupled receptor where it does have a cell surface receptor that it will activate." (said at 1:28:16)

Beta-hydroxybutyrate (BHB) is well established in the scientific literature as both an oxidative metabolic fuel and an active signaling molecule. BHB functions as an endogenous agonist for cell-surface G-protein coupled receptors, particularly hydroxycarboxylic acid receptor 2 (HCAR2, also known as GPR109A), through which it modulates immune cell function and mediates anti-inflammatory effects, alongside other epigenetic and intracellular signaling mechanisms.

1:28:40overstatedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A clinical study in women with polycystic ovary syndrome (PCOS) demonstrated that exogenous ketone supplementation improved metabolic markers and clinical outcomes of PCOS as a standalone intervention.

"there was just a study in women with PCOS. The only intervention was to give them exogenous ketones, and every outcome related to metabolic markers and PCOS got better, and the only change was the supplementation with exogenous ketones." (said at 1:28:40)

A 2025 randomized, placebo-controlled crossover trial (PMID: 40393075) evaluated the acute effects of exogenous beta-hydroxybutyrate (BHB) supplementation in 20 women with PCOS over a 10-hour window (two doses). The trial observed acute reductions in fasting plasma glucose (-10%, p < 0.001) and circulating androgens, including 11-ketotestosterone (-21%, p = 0.020) and trend-level reductions in free testosterone (-21%, p = 0.057) and total testosterone (-13%, p = 0.067). Another small trial (PMID: 41494652, n = 10 PCOS) showed acute ketone monoester intake improved flow-mediated dilation and reduced glucose area under the curve during an oral glucose tolerance test. However, claiming that 'every outcome related to metabolic markers and PCOS got better' overstates the evidence: these studies measured acute, short-term surrogate biomarkers over hours, rather than sustained improvements in clinical PCOS outcomes (such as ovulatory frequency, hyperandrogenic symptoms, hirsutism, or long-term metabolic health).

1:31:44unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In Dr. George Cahill's fasting studies, keto-adapted subjects who reached blood glucose levels as low as 20 mg/dL experienced no cognitive deficits.

"Dr. George Cahill's work, and he was really one of the more famous, prominent what they called at the time starvation scientists—we would call fasting scientists. But that same study I mentioned where it made you wonder, why was it that these patients who got down to 20 milligrams per deciliter of glucose—many people will say that's lethal, like it'll kill you—and yet they not only didn't die, they had no cognitive deficit whatsoever." (said at 1:31:44)

No published record matching the claim that subjects in Dr. George Cahill's fasting studies reached blood glucose levels of 20 mg/dL without cognitive deficits was located; this does not prove the claim false.

1:32:24supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

The brain can use lactate as an energy fuel, albeit to lower levels than glucose and ketones.

"Although the brain does use lactate as a fuel as well, albeit to lower levels." (said at 1:32:24)

Extensive physiological and biochemical research supports that the brain can utilize lactate as an oxidative energy substrate via neuronal and astrocytic lactate shuttles and blood-borne uptake during periods of elevated circulating lactate (such as intense exercise). However, glucose remains the brain's primary fuel, and ketone bodies serve as the major alternative fuel during prolonged fasting or ketogenic states, with lactate acting as a supplemental or opportunistic substrate under specific conditions.

1:35:25supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Palmitate directly activates TLR4 (Toll-like receptor 4), which subsequently drives the synthesis of ceramides.

"You have palmitate coming out that will directly be activating TLR4, the receptor that's going to then drive ceramides to be synthesized." (said at 1:35:25)

Preclinical and in vitro studies demonstrate that saturated fatty acids like palmitate stimulate Toll-like receptor 4 (TLR4) signaling, which upregulates key enzymes (such as serine palmitoyltransferase) required for de novo ceramide biosynthesis and contributes to lipid-induced insulin resistance. Because this mechanism is established primarily in rodent models and cultured cell lines, human clinical certainty is very low.

1:35:50supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Adipocytes can expand up to 20 times their original volume.

"a fat cell can undergo more expansion than any other cell in the body that I'm aware of. It can get 20 times bigger than its original volume." (said at 1:35:50)

Adipocytes possess exceptional capacity for cellular expansion and hypertrophy. Biological reviews document that adipocytes can expand in volume by several hundred-fold to up to a thousand-fold during lipid accumulation and adipose tissue remodeling, easily encompassing a 20-fold increase in volume.

1:38:05contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

The United States ranks around 70th in the world for diabetes prevalence, while Singapore ranks around 9th and Middle Eastern countries occupy ranks 1 through 8.

"I think the US ranks somewhere in the 70s of, if you look at all the countries in the world and how diabetic they are, we're about number 70. Whereas Singapore, for example, and Japan is not too far back—Singapore is I think number nine, and all the countries of the Middle East are actually numbers one through eight, like Oman, Dubai, Jordan, these countries in the Middle East." (said at 1:38:05)

Global epidemiological data on adult diabetes prevalence (such as pooled analyses from the NCD Risk Factor Collaboration published in The Lancet and the International Diabetes Federation Atlas) contradict the speaker's specific ranking claims. Pacific island nations in Polynesia and Micronesia (such as American Samoa, Nauru, and Marshall Islands) consistently have the highest age-standardised diabetes prevalence in the world (exceeding 25–30%), rather than Middle Eastern countries occupying ranks 1 through 8 exclusively. Furthermore, Singapore does not rank 9th globally, and Japan has among the lowest prevalence rates in the developed world, particularly among women. Additionally, Dubai is a city/emirate within the United Arab Emirates, not an independent country.

1:38:50needs contextlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A study found that South Asian men have subcutaneous adipocytes that are approximately four times larger volumetrically than Caucasian men matched for body size and body fat percentage.

"there's one paper I'm recalling where it took Caucasian men and South Asian men and did an adipose subcutaneous biopsy, and it found that the average South Asian man had adipocytes that were about four times larger volumetrically than the fat cells in the Caucasian at the same body size, same body fat percent." (said at 1:38:50)

The speaker accurately references a study comparing subcutaneous abdominal adipose tissue biopsies between South Asian and Caucasian men (Abate et al., 2007, PMID 17726542). The study found that South Asian men had subcutaneous abdominal adipocyte cross-sectional areas more than twice as large as Caucasian men (3,491 ± 1,393 µm² vs 1,648 ± 864 µm²), which corresponds mathematically to approximately a 3-fold difference in cell volume. However, while the groups were matched for age and BMI, they were not matched for total body fat percentage (South Asian men had significantly higher body fat percentage at 22% vs 15%), though differences in adipocyte size persisted when comparing subgroups matched for subcutaneous abdominal fat mass.

1:40:50unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Estrogens stimulate a higher degree of adipose hyperplasia in women compared to men, resulting in more numerous but smaller fat cells.

"women, because of the effects of estrogens, are able to stimulate a higher degree of hyperplasia than her male counterparts are... Because women will have more fat cells, but smaller because of estrogens." (said at 1:40:50)

No published record matching the claim that estrogens stimulate a higher degree of adipose hyperplasia in women compared to men, resulting in more numerous but smaller fat cells, was located; this does not prove the claim false.

1:44:30overstatedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

The primary origin of fat in fatty liver disease is the spillover of free fatty acids from fat cells, particularly visceral fat.

"In fact, the main cause of fatty liver is spillover of fat from fat cells, especially visceral fat. That's the main origin of all that fat." (said at 1:44:30)

The claim is partially supported regarding the overall source of hepatic fat, but overstated regarding the specific contribution of visceral fat. Quantitative metabolic tracer studies show that the largest biological source of hepatic triacylglycerol in nonalcoholic fatty liver disease is circulating nonesterified fatty acids (NEFAs) from adipose tissue lipolysis (~59%), followed by hepatic de novo lipogenesis (~26%) and direct dietary fat (~15%). However, catheterization and isotope dilution studies show that splanchnic (visceral) lipolysis accounts for only ~10% to 50% (and typically under 20–30%) of hepatic fatty acid delivery, with subcutaneous adipose tissue contributing the majority of circulating fatty acids that reach the liver due to its substantially larger overall mass.

1:46:07needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

C-reactive protein is a better predictor of heart disease than LDL cholesterol.

"C-reactive protein is a better predictor of heart disease than LDL cholesterol is." (said at 1:46:07)

The claim stems from landmark prospective cohort findings (such as the Women's Health Study of 27,939 women), which found that baseline high-sensitivity C-reactive protein (hs-CRP) exhibited a steeper relative risk gradient across quintiles (RR up to 2.3) for first cardiovascular events than LDL cholesterol (RR up to 1.5) and concluded CRP was a stronger predictor. However, broader multi-cohort individual-participant meta-analyses (e.g., the Emerging Risk Factors Collaboration across >240,000 participants) demonstrate that while CRP is an independent predictor, its addition to standard risk models containing cholesterol metrics provides modest incremental discrimination (increasing the C-index by ~0.0039). Furthermore, LDL cholesterol is an established causal factor in atherogenesis, whereas CRP is a marker of vascular and systemic inflammation, making them complementary rather than mutually exclusive risk markers.

1:46:15contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Adipose tissue is the primary source of plasminogen activator inhibitor-1 (PAI-1) in the body.

"And and and the fat cell is the main source of a protein called plasminogen activator inhibitor-1, PAI-1, whose main job is to erode clots as they form." (said at 1:46:15)

The speaker's statement contains two distinct assertions with contrasting accuracy. While visceral adipose tissue is indeed a major source of plasminogen activator inhibitor-1 (PAI-1), particularly in state of obesity, the claim regarding PAI-1's biological function is inverted. PAI-1 does not erode blood clots; rather, as an inhibitor of tissue plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), its function is to suppress fibrinolysis and prevent the breakdown of blood clots, thereby promoting clot persistence.

1:47:10needs contextvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

4-HNE, a peroxidation metabolite of linoleic acid, inhibits the hyperplasia potential of fat cells and forces hypertrophic fat growth.

"Specifically, when linoleic acid is taken into the cell, one of its peroxide metabolites that it can turn into is a molecule called 4-HNE. And 4-HNE has been shown to inhibit the fat cell's potential for hyperplasia, thus forcing the fat cell to only go down hypertrophy." (said at 1:47:10)

4-Hydroxynonenal (4-HNE) is a well-established lipid peroxidation byproduct of omega-6 polyunsaturated fatty acids, including linoleic acid. In vitro studies using human adipose-derived stem cells, subcutaneous preadipocytes, and cell lines demonstrate that 4-HNE exposure inhibits adipogenic differentiation (the hyperplasia pathway of adipose tissue). When the formation of new fat cells from precursors is impaired, adipose tissue expansion under positive energy balance is driven predominantly by the enlargement (hypertrophy) of existing adipocytes. However, this model is based on cell culture and ex vivo tissue biopsy mechanisms rather than clinical or in vivo whole-body outcome trials.

1:49:05needs contextvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Dr. Stephen Cunnane's research documented that rapid oxidation of linoleic acid enables the brain to synthesize its own ketones.

"Even Dr. Stephen Cunnane, this incredible man, just a delightful individual, he's done a lot of work documenting the fact that linoleic acid, when it's allowed to just be burned for fuel, burns so high and so rapid that it create—it allows the brain to create its own ketones." (said at 1:49:05)

Dr. Stephen Cunnane's research documented that 18-carbon polyunsaturated fatty acids, including linoleic acid and alpha-linolenic acid, are predominantly metabolized via rapid beta-oxidation rather than being preserved intact. In animal tracer studies (suckling rats and neonatal monkeys), Cunnane and colleagues showed that the oxidized carbon skeletons from linoleate readily generate ketones and acetyl-CoA, which the developing brain utilizes as primary substrates for in situ de novo synthesis of brain cholesterol and fatty acids (carbon recycling). However, this research primarily characterizes linoleate as a systemic ketogenic precursor feeding neonatal brain lipid synthesis rather than demonstrating that the adult human brain directly oxidizes linoleic acid to produce ketones for its own general energetic needs.

1:52:12needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Dr. Christopher Ramsden at the NIH published research showing that soybean oil has become the leading source of fat calories in the human diet.

"Dr. Christopher Ramsden at the NIH a number of years ago published a report finding that soybean oil has become the number one consumed source of fat calories in the human diet." (said at 1:52:12)

Dr. Christopher Ramsden and colleagues at the NIH co-authored a landmark 2011 study analyzing historical food disappearance data in the United States from 1909 to 1999 (Blasbalg et al., Am J Clin Nutr). They found that per capita consumption of soybean oil increased more than 1,000-fold over the 20th century, becoming by far the largest source of dietary linoleic acid and added fat in the American diet. However, the study specifically evaluated the United States diet using USDA economic disappearance data, rather than the global 'human diet'.

2:00:00supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Dr. Roger Unger published papers demonstrating that inhibiting glucagon excess in type 1 diabetes corrects hyperglycemia without requiring insulin administration.

"Dr. Roger Unger at UT Southwestern over years published a series of mind-blowingly cool papers finding that in type 1 diabetes, if you just control the glucagon excess, you don't even need to give the patient insulin, that you could correct all hyperglycemia by just inhibiting the glucagon." (said at 2:00:00)

Dr. Roger Unger and colleagues at UT Southwestern published multiple landmark studies demonstrating that genetic deletion or monoclonal antibody blockade of the glucagon receptor prevented or normalized hyperglycemia and diabetic complications in completely insulin-deficient type 1 diabetic rodent models without the administration of insulin (e.g., Lee et al., 2011; Wang et al., 2015). Because these findings were established in rodent models, evidence evaluating insulin-free management in human type 1 diabetes remains strictly preclinical (graded very low certainty); human clinical trials using glucagon receptor antagonists (such as REMD-477) have demonstrated significant reductions in daily insulin requirements and improved glycemic control, rather than complete elimination of insulin therapy.

2:00:53supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Hyperinsulinemia can be present and detectable decades before a person develops clinical hyperglycemia.

"But we know decades potentially before the person ever starts to have hyperglycemia, they have hyperinsulinemia." (said at 2:00:53)

Longitudinal cohort studies with decades of follow-up demonstrate that insulin resistance and compensatory hyperinsulinemia (elevated insulin secretion) precede the onset of clinical hyperglycemia and type 2 diabetes by 10 to 25 years while blood glucose concentrations remain within the normal range. For example, a 25-year prospective study of offspring of individuals with type 2 diabetes showed that marked insulin resistance and compensatory hyperinsulinemia were detectable more than a decade before diabetes developed in normoglycemic individuals. Similarly, long-term data from the Whitehall II prospective cohort demonstrated compensatory changes in insulin sensitivity and secretion up to 13 years prior to the diagnosis of diabetes, whereas marked increases in fasting and postprandial glucose occurred only in the 3 to 5 years immediately preceding diagnosis.

2:01:57supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Fat cells have an average lifespan of about 10 years.

"Now, however, a fat cell has a lifespan of about 10 years. And so, depending on the utility of that fat cell, it may not be replaced or it may be replaced." (said at 2:01:57)

Human retrospective carbon-14 dating studies demonstrate that human adipocytes turn over at a rate of approximately 10% per year across adulthood in both lean and obese individuals, corresponding to an average fat cell lifespan of approximately 10 years.

2:02:04supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Fat cell count is largely determined during childhood and puberty, and adult weight gain in average individuals occurs primarily through hypertrophy rather than hyperplasia.

"during infancy, childhood, puberty, we're making fat cells. And then for the most part, the number of fat cells we have is set. Now women have a little buffer, like I said earlier, but even then you could have a person who gains 100 more pounds or 200 more pounds in adulthood. For the for the average individual, that's hypertrophy, not a result of hyperplasia." (said at 2:02:04)

Landmark research using retrospective 14C birth dating of adipocytes demonstrates that total fat cell number increases during childhood and adolescence and stabilizes in adulthood across both lean and obese individuals. In adults, fat mass changes are primarily driven by adipocyte hypertrophy (enlargement of existing cells via lipid storage) rather than substantial increases in total adipocyte count, although experimental overfeeding studies note that some lower-body subcutaneous depots can generate new adipocytes (hyperplasia) under specific conditions.

2:02:34contradictedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Fat cell turnover declines in older age (around 60 to 70 years old), leading to a net reduction in the total number of fat cells.

"But then when we get to older age, then the number of fat cells stop turning over. So as they start dying at their 10-year lifespan, we don't replace them. And so at the end of life we have a little drop off in the number of fat cells." (said at 2:02:34)

The speaker claims that fat cell turnover ceases in older age, resulting in fat cells dying after their ~10-year lifespan without replacement and leading to a drop-off in total fat cell number at the end of life. Landmark human studies measuring adipocyte turnover via bomb-pulse 14C dating demonstrate that adipocyte number remains constant throughout adulthood, and fat cell renewal continues at approximately 10% per year across all adult ages. While lipid turnover (the rate of lipid removal and storage within fat cells) decreases with age (as shown by Arner et al., 2019), fat cell turnover itself does not stop, and there is no evidence of a total fat cell drop-off due to unreplaced adipocyte death in older age.

2:02:48supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Studies show that removing substantial body fat via liposuction does not improve any cardiometabolic outcomes.

"And in fact, if you force artificial weight loss by sucking out fat cells where you are just sucking out the fat cells and reducing fat cell number, then you don't improve any cardiometabolic outcome whatsoever. So there's many studies that show that you can have people lose a significant amount of fat through liposuction, and there not a single outcome has improved." (said at 2:02:48)

The claim is supported by high-quality clinical trial evidence and meta-analyses. A landmark study published in the New England Journal of Medicine (PMID 15201411) evaluated the effect of large-volume abdominal liposuction (removing ~10 kg of fat) in women with abdominal obesity (both with and without type 2 diabetes) and found no significant improvements in liver, muscle, or adipose tissue insulin sensitivity, blood pressure, plasma glucose, lipid levels, or inflammatory markers (CRP, IL-6, TNF-alpha, adiponectin). A meta-analysis (PMID 23899478) similarly concluded that subcutaneous fat removal fails to reduce early cardiovascular or metabolic disease risk factors. While some smaller non-randomized studies report conflicting or isolated changes in specific markers (PMID 28737560), rigorous controlled trials confirm that surgical removal of subcutaneous fat alone does not deliver the cardiometabolic benefits associated with metabolic weight loss.

2:03:00needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Patients on semaglutide undergoing general anesthesia have been found to retain food in their stomach despite fasting for 24 hours.

"like people who go through general surgery and have to be put under for general anesthesia, they found that normally you tell the person, "Don't eat for 24 hours," and their stomach's empty, so they're not going to vomit food up while they're asleep. But they found that if people were on semaglutide, the food was still there and they would still have food in their stomach even though they hadn't eaten for 24 hours." (said at 2:03:00)

The core claim is backed by clinical research: multiple prospective gastric ultrasound and endoscopic studies demonstrate that patients taking semaglutide frequently retain solid food and increased residual gastric content before general anesthesia or sedation, despite adhering to fasting protocols. However, standard preoperative fasting guidelines typically require 6 to 8 hours of fasting for solid food prior to elective surgery, rather than a mandatory 24-hour fast, though semaglutide-induced delayed gastric emptying can cause solid food to remain in the stomach well past standard fasting windows.

2:03:35overstatedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

The delay in gastric emptying caused by GLP-1 receptor agonists can prevent oral medications, such as birth control pills, from being effectively absorbed.

"because of the change in gastric emptying, even some medications like birth control medications don't work anymore, for example, because you've so changed how long it takes that drug to get from the stomach into the the small intestine where it would have been absorbed." (said at 2:03:35)

Pharmacokinetic studies and systematic reviews demonstrate that while GLP-1 receptor agonists (GLP-1 RAs) delay gastric emptying—leading to a delayed time to maximum concentration (tmax) and sometimes modest reductions in peak concentration (Cmax)—they do not meaningfully reduce total systemic exposure (area under the curve, AUC) or bioavailability of oral contraceptive pills. Clinical pharmacology trials of GLP-1 RAs such as liraglutide, dulaglutide, and semaglutide show no clinically significant reduction in oral contraceptive efficacy, and prescribing guidelines do not require dose adjustments or alternative contraception for pure GLP-1 RAs. A temporary reduction in oral contraceptive AUC has been observed with the dual GIP/GLP-1 agonist tirzepatide during dose initiation and escalation, but the assertion that GLP-1 agonists prevent absorption such that birth control pills 'don't work anymore' is contradicted by the pharmacokinetic literature.

2:04:29supportedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Ben Bikman's published case series documented the reversal of insulin resistance over 90 days in patients with type 2 diabetes.

"In fact, that's why with the slow insulin resistance, the reversal of that like over the 90 days in the type 2 diabetic patients that we had in our published case series, uh that would have been—not that we measured this, but it would have been because of a shrinking of the fat cell." (said at 2:04:29)

A published case series co-authored by Benjamin Bikman evaluated 11 adult female patients with recently diagnosed type 2 diabetes undergoing a 90-day ketogenic dietary intervention limiting carbohydrate intake to under 30 grams daily. Over 90 days, mean HbA1c decreased from 8.9% to 5.6%, returning levels to non-diabetic range, alongside significant body weight reduction (85.7 kg to 76.7 kg) and improvements in blood lipid markers of insulin resistance (such as a drop in the triglyceride-to-HDL ratio from 4.7 to 1.9). As an uncontrolled case series, this body of evidence is classified as very low certainty.

2:05:20supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Visceral adipocytes are more responsive to epinephrine-stimulated lipolysis than subcutaneous adipocytes.

"So visceral adipocytes are more responsive to the lipolytic signal, the fat breakdown signal of epinephrine. So, anything that increases epinephrine will have, sort of pound-for-pound or site-for-site, visceral versus subcutaneous is going to have a better visceral response." (said at 2:05:20)

Human ex vivo and metabolic studies demonstrate that visceral (e.g., omental and mesenteric) adipocytes have a higher lipolytic responsiveness and sensitivity to catecholamines (epinephrine and norepinephrine) than subcutaneous adipocytes. This regional variation is driven by greater lipolytic beta-adrenoceptor (beta-1, beta-2, and beta-3) expression/activity and lower antilipolytic alpha-2-adrenoceptor activity in visceral adipose tissue compared to subcutaneous depots, a difference that is particularly pronounced in individuals with central obesity.

2:07:15supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A published study by K. Sreekumaran Nair's group found that insulin is not required for muscle protein synthesis, but serves primarily to inhibit muscle protein breakdown.

"So there was a group—in fact, I think it was the same guy I mentioned earlier, Nair at Minnesota at the time—they published a paper finding that insulin wasn't necessary for muscle protein synthesis... They documented that insulin was not necessary for muscle protein synthesis, but it was very helpful for inhibiting the breakdown. So they suggested that insulin's main effect on muscle is an antiproteolytic effect rather than a stimulating effect." (said at 2:07:15)

Studies conducted by K. Sreekumaran Nair's research group evaluated human muscle protein synthesis and breakdown in response to insulin infusions using stable isotope tracer methodologies. These clinical trials demonstrated that under postabsorptive conditions in adult humans, insulin does not significantly increase skeletal muscle protein synthesis, but instead exerts its anabolic/anticatabolic effect predominantly by suppressing muscle protein breakdown (proteolysis) in a dose-dependent manner.

2:07:50supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Only a low concentration of insulin is required to inhibit muscle proteolysis.

"But it also didn't take a lot of insulin to inhibit the proteolysis." (said at 2:07:50)

Human forearm perfusion and tracer kinetic studies demonstrate that skeletal muscle proteolysis is exquisitely sensitive to insulin. Low physiological increments of plasma insulin (around 20 μU/ml above basal) achieve maximal or near-maximal suppression of muscle protein breakdown (approximately 38-40%), with higher insulin doses providing no substantial additional antiproteolytic effect.

2:11:40supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

At low antidiabetic doses, GLP-1 receptor activators act by inhibiting pancreatic alpha cells and suppressing glucagon secretion.

"So at the lower dose originally used, these GLP-1 activators worked actually by inhibiting glucagon. So back to the alpha cell that I mentioned earlier, we come back to them now, where in type 2 diabetes, the insulin resistance of the alpha cell results in a chronic elevation of glucagon, chronically then telling the liver to be releasing glucose, leading to the hyperglycemia that defines the diabetic state. At this low dose, semaglutide inhibits the alpha cell. It inhibits glucagon, and by inhibiting glucagon, you're helping correct blood glucose." (said at 2:11:40)

GLP-1 receptor agonists (including semaglutide at standard antidiabetic doses) lower blood glucose through complementary mechanisms that include glucose-dependent stimulation of insulin secretion from beta cells and suppression of glucagon secretion from pancreatic alpha cells, which in turn reduces hepatic glucose output. Randomized, double-blind clinical trials in patients with type 2 diabetes demonstrate that therapeutic doses of semaglutide significantly reduce fasting, postprandial, and 24-hour glucagon levels alongside improving glycemic control.

2:12:15contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Arne Astrup has published multiple human studies demonstrating that GLP-1 does not stimulate insulin secretion or act as an insulin secretagogue in humans.

"Now some people have the very mistaken view that semaglutide or GLP-1 activators also release insulin. That is not true. That has been shown to happen in isolated cell cultures, but in humans there's no evidence. And the authority on the subject is a guy named Arne Astrup in Denmark. He's one of the absolute authorities on this topic. He's published multiple papers in humans showing that no amount of GLP-1 elicits an insulin release." (said at 2:12:15)

The claim is contradicted by extensive physiological and clinical trial evidence in humans. Glucagon-like peptide-1 (GLP-1) is an incretin hormone whose hallmark biological action is the glucose-dependent stimulation of insulin secretion from pancreatic beta cells. Decades of human studies, including randomized controlled trials and hyperglycemic clamp experiments, demonstrate that intravenous infusion of GLP-1 as well as GLP-1 receptor agonists (such as semaglutide) robustly stimulate insulin secretion in both healthy individuals and patients with type 2 diabetes. Arne Astrup's published human studies on GLP-1 focus primarily on appetite regulation, gastric emptying, and energy intake rather than claiming that GLP-1 fails to elicit insulin release.

2:12:55supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

GLP-1 receptor agonists delay gastric emptying and slow intestinal peristalsis in humans.

"Within the intestines, GLP-1 will act to delay gastric emptying and slow peristalsis. So that has the effect of a person eating and having that bulk sit in their stomach much longer, which is going to generally discourage them from wanting to eat more." (said at 2:12:55)

Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonists inhibit upper gastrointestinal motility in humans, measurably delaying gastric emptying and slowing small-bowel intestinal transit. A systematic review and meta-analysis of clinical trials found that GLP-1 receptor agonists significantly delayed gastric emptying half-time (T1/2) on scintigraphy by a pooled mean difference of 36.0 minutes compared to placebo. In addition, prospective human clinical studies demonstrate that GLP-1-based therapies significantly prolong small-bowel transit time.

2:17:17supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A 1996 study published in Gut found that while lean and obese individuals had similar GLP-1 responses to a high-fat meal, obese individuals exhibited no statistically significant GLP-1 increase after a high-carbohydrate meal.

"A paper was published in 1996 that looked at the changes in GLP-1 in two populations. They took otherwise healthy humans and split them up, and they noticed changes in the obese group and the lean group. So when they gave both groups a high-fat meal, they looked at the GLP-1 response, and it was roughly similar in both groups... However, when they gave them a high-carb meal, the lean group had a huge increase in GLP-1. The obese group had no statistically significant response whatsoever... It was published in the journal Gut in 1996." (said at 2:17:17)

A 1996 physiological study published in Gut (Ranganath et al.) compared GLP-1 responses to carbohydrate and fat meals in 6 obese and 6 matched lean women. The authors found that while GLP-1 secretion in response to an oral fat meal did not differ between the two groups, GLP-1 secretion after an oral carbohydrate meal was markedly attenuated in the obese subjects compared to lean controls.

2:24:30supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A clinical trial published in the New England Journal of Medicine found that approximately 40% of the total weight lost on semaglutide was lean/fat-free mass.

"The evidence is very real showing—one of the best-looked papers in the New England Journal of Medicine about two, three years ago found that about almost 40% of the weight loss that a person was losing was fat-free mass. Now, that is itself a big pool, but some of it would be muscle and bone mass." (said at 2:24:30)

The claim accurately reflects the body composition sub-study findings of the STEP 1 trial, published in The New England Journal of Medicine (Wilding et al., 2021). In this randomized controlled trial of 1,961 adults with overweight or obesity, 68 weeks of once-weekly semaglutide 2.4 mg combined with lifestyle intervention led to a mean body weight loss of 14.9%. In the exploratory dual-energy X-ray absorptiometry (DEXA) body composition sub-study, fat-free mass loss accounted for approximately 39% (nearly 40%) of the total weight loss, while fat mass reduction accounted for the remaining ~61%.

2:29:40needs contextlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A recently published study found that the risk of developing blindness is more than double in patients taking high-dose GLP-1 receptor agonists.

"with GLP-1, in fact, it's worth noting another paper was just published this week finding that the risk of blindness doubles—more than doubles—in people on high-dose GLP-1s. Paper was just published. So you look at the degree of blindness that occurs in adults, and those using the drug, it was more than twice the risk of developing blindness." (said at 2:29:40)

The speaker is referencing a widely publicized July 2024 observational cohort study published in JAMA Ophthalmology (Hathaway et al.), which investigated the link between semaglutide (a GLP-1 receptor agonist) and nonarteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden optic nerve-related vision loss. That study found a substantially elevated risk of NAION among patients prescribed semaglutide compared to non-GLP-1 medications, both in type 2 diabetes (hazard ratio 4.28) and in overweight/obesity (hazard ratio 7.64). However, characterizing this finding as a general doubling of overall 'blindness' requires important context: NAION is a specific and relatively rare form of optic neuropathy, not overall blindness from all causes. Furthermore, the findings stem from retrospective observational data from a single academic neuro-ophthalmology referral center and demonstrate an association rather than proven causality.

2:31:08unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Longevity studies, including the AMORIS study in Sweden, the Honolulu Heart Program, the Shanghai Aging Study, and Mediterranean studies of centenarians, consistently find that insulin sensitivity and optimal glucose levels correlate with familial longevity.

"And then the longevity studies like the AMORIS study in Sweden or the Honolulu Heart Program or the Shanghai aging study, some of the most consistent variables is metabolic health, optimal glucose levels and insulin sensitivity. In fact, that one study, I think it was in the Mediterranean, that looked at families where you have a high number of centenarians, they found that the most common theme was that they were all very insulin sensitive." (said at 2:31:08)

No published record matching the claim was located; this does not prove the claim false.

2:32:10contradictedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A single dose of insulin activates mTOR for up to 24 hours, whereas leucine only activates mTOR for approximately one to two hours.

"One dose of insulin can activate mTOR for up to 24 hours. Whereas leucine, the most anabolic of the amino acids, will only activate mTOR for about an hour or two." (said at 2:32:10)

While leucine stimulates the mTOR pathway and downstream protein synthesis transiently for approximately 1 to 3 hours (often referred to as the 'muscle full' effect), there is no evidence that a single physiological dose of insulin sustains mTOR activation for up to 24 hours. Both hormonal (insulin) and amino acid signaling pathways regulate muscle protein turnover on a acute timescale of minutes to hours rather than sustained across an entire day from a single dose.

2:33:39supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Approximately 70% of Americans prescribed GLP-1 agonist medications discontinue taking the drug within two years.

"And in fact, 70% in the US, 70% of Americans get off the drug at 2 years either because of cost or nausea or whatever, 70% stop taking it." (said at 2:33:39)

Real-world observational studies and pharmacy claims analyses in the United States show that approximately 60% to 70% of patients discontinue GLP-1 receptor agonist therapy within two years. In cohorts of patients with type 2 diabetes or obesity, persistence drops significantly over time, with real-world discontinuation rates reaching roughly 64% to 70% by 24 months. Common reasons for discontinuation include gastrointestinal side effects (such as nausea and vomiting), high out-of-pocket costs, loss of insurance coverage, and medication supply shortages.

2:33:59supportedlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A study published within the past year found that people on standard Wegovy dosing for up to two years had double the risk of suicidal behavior, triple the risk of major depression, and a 106% increased risk of anxiety.

"a paper was published within the past six months, I think it was within the past six months, definitely within the past year, the risk of suicidal behavior doubles and the risk of major depression triples in people who were on the drug for up to two years... the major depression risk, people were three times more likely to have clinically diagnosed major depression. And again, twice more likely for suicidal behavior and twice as likely, it was like 106% increased risk of anxiety." (said at 2:33:59)

A retrospective cohort study published in October 2024 in Scientific Reports (PMID: 39424950) evaluated post-marketing electronic health records of patients with obesity prescribed GLP-1 receptor agonists (semaglutide and liraglutide) compared to matched controls. The authors reported that GLP-1 RA use was associated with a 195% higher risk of major depression (almost triple), a 108% increased risk of anxiety, and a 106% elevated risk of suicidal behavior (roughly double). However, this evidence comes from observational real-world data subject to residual confounding; subsequent systematic reviews and meta-analyses of randomized trials and active-comparator cohorts have generally found no statistically significant increases in depression, anxiety, or suicidal behaviors associated with semaglutide.

2:37:07contradictedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Giving insulin therapy to type 2 diabetic patients triples their risk of dying from heart disease and doubles their risk of dying from cancer.

"When you give a type 2 diabetic insulin therapy, they get fatter and sicker and die faster, all while glucose looks good. This is well documented. Their risk of dying from heart disease triples. Their risk of dying from cancer doubles when you give them insulin." (said at 2:37:07)

The claim that insulin therapy triples the risk of cardiovascular death and doubles the risk of cancer death in patients with type 2 diabetes is contradicted by randomized controlled trial evidence. In the large-scale ORIGIN trial (12,537 participants followed for over 6 years), basal insulin therapy showed a completely neutral effect on cardiovascular outcomes (HR 1.02, 95% CI 0.94–1.11) as well as cancer incidence (HR 1.00, 95% CI 0.88–1.13) and cancer-specific mortality compared with standard care. While observational studies sometimes report higher mortality among insulin users, this reflects confounding by indication (insulin is prescribed to patients with longer disease duration, more advanced comorbidities, and poorer baseline health), not a causal doubling or tripling of mortality.

2:38:31needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In diabetic retinopathies and nephropathies, excess intracellular glucose is diverted into the sorbitol pathway, where sorbitol accumulation creates an osmotic gradient causing hydropic degeneration and cell rupture.

"And if there's so much glycolysis happening that it starts to inhibit entry into the glycolytic pathway, then you divert the glucose into the sorbitol pathway. Now you have glucose turning into sorbitol, which the cell can't do anything with, and so sorbitol begins to accumulate in the cell and that starts to increase the osmotic gradient into the cell. And now you have basically a water balloon that's getting overfull, and you have this what's called hydropic degeneration, where you basically force water into the cell because of this glucose metabolite, and then the cell can burst. And this is a large part of the problem with macular degeneration and retinopathies. In the nephropathies of the kidney, the main mechanism whereby the glucose is damaging, or one of the main mechanisms, is the conversion of the glucose into sorbitol." (said at 2:38:31)

The speaker correctly identifies the polyol (sorbitol) pathway as a key mechanism in hyperglycemia-induced diabetic microvascular complications, including diabetic retinopathy and nephropathy. Under hyperglycemic conditions, excess intracellular glucose is reduced to sorbitol by aldose reductase, leading to intracellular sorbitol accumulation, osmotic swelling/stress, and oxidative stress. However, the claim oversimplifies and conflates aspects of the mechanism: classic osmotic swelling leading to cell rupture (e.g. hydropic changes/cataract formation) was primarily demonstrated in the lens (cataractogenesis) and early polyol research, whereas in diabetic retinopathy and nephropathy, polyol pathway flux causes cellular damage primarily through osmotic stress, oxidative stress (NADPH depletion and altered NADH/NAD+ redox ratio), and downstream inflammatory/metabolic signaling rather than simple physical ballooning and cell rupture. Additionally, the speaker erroneously mentions macular degeneration (age-related macular degeneration is a distinct pathology from diabetic retinopathy, though diabetic macular edema occurs).

2:40:42supportedmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

The AMORIS study from Sweden demonstrated that uric acid levels and blood glucose control were predictive biomarkers of longevity.

"that really well-done longevity study, the AMORIS study from Sweden, found that uric acid was one of the very few predictors that when they looked retrospectively at these people measuring the same markers for decades, their glucose control was a predictive variable and their uric acid was a predictive variable as to who lived the longest, healthiest lives." (said at 2:40:42)

A 35-year follow-up study of the Swedish AMORIS cohort published in GeroScience (Murata et al., 2024) investigated blood biomarker profiles measured between ages 64 and 99 in relation to exceptional longevity (reaching age 100). The analysis of 1,224 centenarians compared to shorter-lived peers demonstrated that lower blood glucose and lower uric acid levels (along with lower creatinine, liver enzymes, and higher total cholesterol and iron) were significantly associated with the chance of reaching 100 years of age.

2:41:44unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A triglyceride-to-HDL ratio below 1.5 corresponds to a predominance of large buoyant (Pattern A) LDL particles, whereas a higher ratio reflects small dense (Pattern B) LDL particles.

"It actually looks at the difference in population of the big LDL, the buoyant, versus the small dense LDL. And wouldn't you know it, right around that triglyceride to HDL ratio on the x-axis of 1.5 is that crossover. So as the triglyceride to HDL ratio was higher, it reflected a higher particle B, or pattern B rather, LDL. The lower the triglyceride to HDL ratio was, the more it reflected a pattern A, the large buoyant, apparently less atherogenic." (said at 2:41:44)

No published record matching the claim that a triglyceride-to-HDL ratio cutoff of 1.5 precisely demarcates LDL phenotype pattern A (large buoyant LDL) from pattern B (small dense LDL) was located; this does not prove the claim false.

2:41:56unverifiedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Bitter tastants reduce cravings for sweet foods.

"whether it's drinking some apple cider vinegar or having something bitter in your mouth to reduce the sweet cravings—because bitter tastants can reduce sweet cravings—I would say do it." (said at 2:41:56)

No published record matching the claim that oral bitter tastants or bitter substances reduce cravings for sweet foods was located; this does not prove the claim false.

2:42:01supportedhighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Advanced glycation end-products (AGEs) bind to and activate the receptor for advanced glycation end-products (RAGE), triggering inflammatory cascades.

"when you form an advanced glycation end-product, it becomes a ligand for RAGE, the receptor for advanced glycation end-products. And when RAGE gets activated, you have a lot of inflammation." (said at 2:42:01)

Advanced glycation end-products (AGEs) serve as ligands that bind to the receptor for advanced glycation end-products (RAGE). Binding and activation of RAGE stimulate downstream intracellular signaling pathways, such as NF-κB and MAPKs, which drive pro-inflammatory gene expression, cytokine production, and oxidative stress across metabolic, vascular, and inflammatory disease states.

2:42:30overstatedvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Hypoglycemia disrupts circadian melatonin rhythms.

"Hypoglycemia disrupts melatonin, too. So even back to the glucose mechanism, another reason to not go to bed hypoglycemic is it disrupts the melatonin rhythm at the same time." (said at 2:42:30)

The claim that hypoglycemia disrupts circadian melatonin rhythms (and serves as a reason not to go to bed hypoglycemic) is based on early animal stress models rather than human clinical evidence. In rodents, acute severe insulin-induced hypoglycemia acts as a physiological stressor that triggers catecholamine release and transiently stimulates pineal N-acetyltransferase (NAT) activity and melatonin synthesis via beta-adrenergic receptors. However, evidence demonstrating that bedtime hypoglycemia impairs or disrupts the nocturnal circadian melatonin rhythm in humans is lacking.

2:43:41needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Glucose-derived polyols such as sorbitol and mannitol cannot passively cross cell membranes.

"these derivatives of glucose, like sorbitol or mannitol, they can't move across cell membranes." (said at 2:43:41)

Glucose-derived polyols like sorbitol and mannitol have very low passive lipid bilayer permeability, which explains why sorbitol accumulates intracellularly during hyperglycemia (causing osmotic stress) and why mannitol acts as an extracellular osmotic agent. However, claiming that they absolutely cannot move across cell membranes requires qualification: several cell types possess carrier-mediated transport mechanisms, including sorbitol permeases, volume-activated channels, and low-affinity transport via hexose transport systems.

2:44:42needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Skeletal muscle tissue does not express glucagon receptors.

"Muscle doesn't have glucagon receptors. Like, it's very much tissue specific." (said at 2:44:42)

Classically and functionally in human physiology, skeletal muscle does not respond to glucagon or express physiologically significant glucagon receptors, which explains why glucagon stimulates glycogenolysis in the liver but not in skeletal muscle. However, stating that muscle completely lacks glucagon receptors requires context: sensitive molecular profiling studies have detected low/basal levels of glucagon receptor (GCGR) mRNA transcripts in skeletal muscle tissue.

Fact-checked episodes

Publications

No PubMed publication profile has been built for this speaker yet.